Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Adding pregabalin (Lyrica) to existing therapy for poorly controlled partial seizures reduces seizure frequency and is generally well tolerated over the long term,…
NEW YORK (Reuters Health) – Pooled data from multiple studies indicate that repetitive transcranial magnetic stimulation (rTMS) is useful for depression, auditory verbal hallucinations, and possibly for negative…
NEW YORK (Reuters Health) – A bolus of etomidate before rapid sequence intubation has a transient effect on adrenal function with no obvious affect on mortality, according to…
NEW YORK (Reuters Health) – In nondiabetics, high glucose levels signal an increased risk for contrast-induced acute kidney injury during coronary angiography, new research suggests. “Although diabetes is…
NEW YORK (Reuters Health) – Active surveillance for renal cortical neoplasm is a “reasonable treatment option” in older patients with comorbid illness, according to a single-center report from…
NEW YORK (Reuters Health) – Most women with gestational diabetes do not require insulin while they’re giving birth, Spanish researchers report in the American Journal of Obstetrics and…
NEW YORK (Reuters Health) – The advantages of primary percutaneous coronary intervention (PCI) over fibrinolysis for patients with ST-segment elevation myocardial infarction (STEMI) are maintained for 8 years,…
NEW YORK (Reuters Health) – Rib fractures in older men are often associated with risk markers for osteoporosis, such as low bone density and a history of fracture,…
NEW YORK (Reuters Health) – Treatment with dutasteride reduces incident prostate cancers in men with high prostate specific antigen (PSA) levels, according to a report in The New…
NEW YORK (Reuters Health) – Sequential screening for type 2 diabetes is cost effective when started between the ages of 30 and 45 years and repeated every 3…
